Results for tag: "Pulmonary Embolism Drug"

The Pulmonary Embolism Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat pulmonary embolism, a condition in which a blood clot blocks one or more arteries in the lungs. These drugs are typically anticoagulants, which work by preventing the formation of new blood clots and dissolving existing ones. Other drugs used to treat pulmonary embolism include thrombolytics, which break down existing clots, and thrombin inhibitors, which prevent the formation of new clots. The Pulmonary Embolism Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Bayer, and Bristol-Myers Squibb. Other companies in the market include Merck, Novartis, AstraZeneca, and Boehringer Ingelheim. Show Less Read more